Dr Lindsay Heber, PSYD | |
28204 Picadilly Pl, Castaic, CA 91384-3830 | |
(661) 721-6300 | |
Not Available |
Full Name | Dr Lindsay Heber |
---|---|
Gender | Female |
Speciality | Psychologist - Forensic |
Location | 28204 Picadilly Pl, Castaic, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700322633 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TF0200X | Psychologist - Forensic | PSY28466 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lindsay Heber, PSYD 28204 Picadilly Pl, Castaic, CA 91384-3830 Ph: (661) 721-6300 | Dr Lindsay Heber, PSYD 28204 Picadilly Pl, Castaic, CA 91384-3830 Ph: (661) 721-6300 |
News Archive
Reduced volume, or atrophy, in parts of the brain known as the amygdala and hippocampus may predict which cognitively healthy elderly people will develop dementia over a six-year period, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
HHS Secretary Kathleen Sebelius said Sunday the U.S. has agreed to put an addition $1 billion towards ingredients for the production of a vaccine that offers protection against the H1N1 (swine flu) virus, Reuters reports.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy.
The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.
Janssen announced today that the U.S. Food and Drug Administration (FDA) has approved a broader indication for the oral, once-daily medication ZYTIGA (abiraterone acetate).
› Verified 3 days ago
Dr. Amanda Tekinceer, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 29010 Capri Ct, Castaic, CA 91384 Phone: 937-204-5500 |